ANASTASIS BIOTEC
Anastasis Biotec is a developer of a novel and proprietary treatment made for patients with cancers that express specific ‘cancer-driving mutations’.
ANASTASIS BIOTEC
Industry:
Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.anastasisbiotec.com
Total Employee:
1+
Status:
Active
Total Funding:
236.66 K GBP
Technology used in webpage:
German Server Location
Similar Organizations
AvonGreen Scientific
AvonGreen Scientific supplies medical supplies that include hospital consumables, instruments, equipment, reagents, and chemicals.
Fedialis Medica
Fedialis Medica provider of healthcare services and proprietary information technology.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
RQ Bio
RQ Bio develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
Crowdcube
Crowdcube investment in Equity Crowdfunding - Anastasis Biotec
Official Site Inspections
http://www.anastasisbiotec.com
- Host name: 217-160-0-47.elastic-ssl.ui-r.com
- IP address: 217.160.0.47
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Anastasis Biotec"
ANASTASIS BIOTEC
Anastasis’ Technology The technology relates to a novel treatment applicable to many cancers. These cancers depend on rogue cells multiplying uncontrollably caused by DNA abnormalities (mutations) in important pathways involved in …See details»
Anastasis Biotec - Crunchbase Company Profile & Funding
Anastasis Biotec is a developer of a novel and proprietary treatment made for patients with cancers that express specific ‘cancer-driving mutations’.See details»
ANASTASIS BIOTEC LIMITED - Companies House
ANASTASIS BIOTEC LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
ANASTASIS BIOTEC LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ANASTASIS BIOTEC LIMITED of LONDON. Get the latest business insights from Dun & Bradstreet.See details»
Anastasis Biotec Limited - Company Profile - Endole
Nov 29, 2016 Anastasisbiotec.com. See All Contacts . People. Officers. 3. Shareholders. 46. Controllers (PSC) 1. Dr Agamemnon Antoniou Epenetos. Director • PSC • Doctor • British • …See details»
Anastasis Biotec - LinkedIn
Anastasis’ technology relates to a novel treatment applicable to many cancers. These cancers depend on rogue cells multiplying uncontrollably caused by DNA abnormalities (mutations) in …See details»
Anastasis Biotec Limited - London NW3 2BH (Greater London
SIC (GB 2007) : Research and experimental development on biotechnology (72110 ) NACE Rev.2 (EU 2008) : Research and experimental development on biotechnology (7211) ISIC 4 …See details»
Anastasis Biotec - PitchBook
Anastasis Biotec General Information Description. Developer of cancer therapeutics designed to serve as a novel, effective, and proprietary cancer treatment method. The company's therapeutics essentially act as cancer …See details»
Anastasis Biotec Overview | SignalHire Company Profile
Anastasis Biotec is a developer of a novel and proprietary treatment made for patients with cancers that express specific ‘cancer-driving mutations’.See details»
Anastasis Biotec Ltd. - Drug pipelines, Patents, Clinical trials
Explore Anastasis Biotec Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Anastasis Biotec - Overview, News & Similar companies - ZoomInfo
Popular Searches ANASTASIS BIOTEC Ltd Anastasis Biotec Anastasisbiotec SIC Code 87,873 NAICS Code 54,541 Show more. Similar Companies to Anastasis Biotec. Rexgenero Ltd <25 …See details»
ANASTASIS BIOTEC LIMITED more information - Find and update …
ANASTASIS BIOTEC LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Anastasis Biotec Ltd - Legal Entities - Tracxn
Anastasis Biotec Ltd is a Private Limited Company and was incorporated on Nov 28, 2016 in United Kingdom. Its corporate identification number is (CIN) 10502511 and its current status is …See details»
Anastasis Biotec - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 10, 2020: Equity …See details»
Anastasis Biotec - Contacts, Employees, Board Members
Anastasis Biotec is a developer of a novel and proprietary treatment made for patients with cancers.See details»
Anastasis Biotec - Company Profile - Tracxn
Anastasis Biotec - Developer of cancer therapeutics. Raised a total funding of $310K over 1 round. Anastasis Biotec has 2799 competitors.See details»
Anastasis Biotec Ltd.:Company Profile & Technical …
Anastasis Biotec Ltd. is headquartered in United Kingdom . Anastasis Biotec Ltd. was founded in 2016. Anastasis Biotec Ltd. has a total of 12 patentsSee details»
ANASTASIS BIOTEC LIMITED people - Find and update company …
ANASTASIS BIOTEC LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Anastasis Biotec Ltd – Wholesale Investor
Executive Summary . Anastasis Biotec (ABL) is a biopharmaceutical company focused on developing disruptive therapeutic drugs in Oncology and Virology.See details»
ANASTASIS BIOTEC LIMITED - VentureRadar
Similar Companies: SynRx Therapeutics China Privately Held SynRx Therapeutics is an innovative R&D company focusing on the development of novel anti-tumor drugs using …See details»